Selected stock price target news of the day - July 18th, 2025

By: Matthew Otto

Netflix Raises Full-Year Revenue Outlook After Q2 Beat, But Warns of Margin Pressure

Netflix reported second-quarter 2025 earnings per share (EPS) of $7.19, exceeding the analyst consensus estimate of $7.07 by $0.12 Quarterly revenue reached $11.08 billion, slightly ahead of the $11.04 billion consensus forecast.

Net income rose to $3.1 billion, up from $2.1 billion in the same quarter a year earlier. The operating margin expanded to 34.1%, compared to 27.3% in Q2 2024 and 31.7% in Q1 2025. Operating cash flow was $2.4 billion, reflecting an increase of more than 84% year-over-year, while free cash flow grew 91% to $2.3 billion.

Netflix updated its full-year 2025 revenue guidance to a range of $44.8 billion to $45.2 billion, surpassing both its previous outlook of $43.5 billion to $44.5 billion and the current analyst consensus of $44.5 billion. As in the prior quarter, Netflix did not disclose subscriber metrics, continuing its shift toward emphasizing financial performance. The full-year free cash flow forecast was also raised to between $8 billion and $8.5 billion, up slightly from a previous estimate of approximately $8 billion.

Analysts Lift Ratings and Targets on Q2 Beat and Raised Guidance

Piper Sandler analyst Matt Farrell maintained an Overweight rating and lifted the price target from $1,400 to $1,500.
Morgan Stanley analyst Benjamin Swinburne maintained an Overweight rating and boosted the price target from $1,450 to $1,500.
Needham analyst Laura Martin reiterated a Buy rating and the price target $1,500.
Rosenblatt analyst Barton Crockett raised the price target to $1,515.
Canaccord Genuity analyst Maria Ripps reiterated a Buy rating and a price target of $1,525.
Goldman Sachs analyst Eric Sheridan raised the price target from $1,140 to $1,310.

Which Analyst has the best track record to show on NFLX?

Analyst David Joyce (SEAPORT) currently has the highest performing score on NFLX with 4/4 (100%) price target fulfillment ratio. His price targets carry an average of $112.63 (13.37%) potential upside. Netflix stock price reaches these price targets on average within 26 days.

Cintas Tops Q4 EPS and Revenue Estimates; Posts Broad-Based Growth for Fiscal 2025

Cintas reported fourth-quarter fiscal 2025 earnings per diluted share of $1.09, exceeding the consensus estimate of $1.07 by $0.02. Quarterly revenue reached $2.67 billion, also above the analyst estimate of $2.63 billion.

Compared to the same period last year, revenue increased 8%, or 9.6% on a same workday basis, while organic revenue growth stood at 9%. Gross margin rose 9.1% year over year to $1.33 billion, representing 49.7% of revenue, up from 49.2%.

Operating income for the quarter reached $597.5 million, or 22.4% of revenue, compared to $547.6 million and 22.2% a year ago. Net income totaled $448.3 million, up 8.2%, with the effective tax rate increasing to 22.1% from 21.4%, largely due to discrete tax items related to stock-based compensation.

For the full fiscal year ended May 31, 2025, revenue rose 7.7% to $10.34 billion, or 8.6% on a same workday basis. Organic revenue growth for the year was 8%. Operating income increased 14.1% to $2.36 billion, representing 22.8% of total revenue, compared to 21.6% in the prior year. Full-year net income reached $1.81 billion, a 15.3% increase from fiscal 2024, while diluted EPS rose 16.1% to $4.4. Cash flow from operations totaled $2.17 billion, with $1.76 billion in free cash flow.

Cintas spent $408.9 million on capital expenditures, made $232.9 million in acquisitions, paid $611.6 million in dividends, and repurchased 3.8 million shares at an average price of $179.07 per share for a total of $679.3 million. Guidance for fiscal 2026 includes projected revenue between $11 billion and $11.15 billion and diluted EPS in the range of $4.71 to $4.85.

Analysts Adjust Price Targets Following Q4 Earnings

Baird analyst Andrew Wittmann maintained a Neutral rating but raised the price target from $227 to $230.
Morgan Stanley analyst Toni Kaplan reiterated an Equal-Weight rating and increased the price target from $213 to $220.

Which Analyst has the best track record to show on CTAS?

Analyst Jason Haas (WELLS FARGO) currently has the highest performing score on CTAS with 4/4 (100%) price target fulfillment ratio. His price targets carry an average of $-3.31 (-1.48%) potential downside. Cintas stock price reaches these price targets on average within 25 days.

Abbott Beats Q2 Estimates with Medical Device Sales; Reaffirms FY2025 Guidance

Abbott reported second-quarter 2025 revenue of $11.42 billion, surpassing the consensus estimate of $11.07 billion. Adjusted earnings per share (EPS) came in at $1.26, $0.01 above analyst expectations.

Abbott recorded 7.4% sales growth on a reported basis and 6.9% organically—or 7.5% when excluding COVID-19 testing-related sales. Adjusted gross margin expanded 100 basis points year over year to 57%, and adjusted operating margin rose to 22.9%. Abbott reaffirmed its full-year 2025 adjusted EPS guidance of $5.1 to $5.2, in line with the current consensus estimate of $5.16.

Medical Devices led performance with 14.2% organic growth. Diabetes Care revenue reached $1.6 billion, driven by increased use of the FreeStyle Libre platform, which the company reports is used by over 6.5 million individuals globally. Electrophysiology sales rose 17.7% organically, reflecting stronger sales of ablation tools used in atrial fibrillation treatment.

Analysts Adjust Ratings and Price Targets Following Results

Mizuho analyst Anthony Petrone maintained a Neutral rating but trimmed the price target from $140 to $135.
Jefferies analyst Matthew Taylor upgraded from Hold to Buy and the price target from $143 to $145.
BTIG analyst Marie Thibault maintained a Buy rating but lowered the price target from $148 to $145.
Wells Fargo analyst Larry Biegelsen lowered the price target to $142.
Stifel analyst Rick Wise reiterated a Buy rating along with a $145 price target.

Which Analyst has the best track record to show on ABT?

Analyst Rick Wise (STIFEL) currently has the highest performing score on ABT with 14/15 (93.33%) price target fulfillment ratio. His price targets carry an average of $14.02 (10.7%) potential upside. Abbott stock price reaches these price targets on average within 298 days.